BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 29329380)

  • 1. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
    Perez-Sanchez C; Font-Ugalde P; Ruiz-Limon P; Lopez-Pedrera C; Castro-Villegas MC; Abalos-Aguilera MC; Barbarroja N; Arias-de la Rosa I; Lopez-Montilla MD; Escudero-Contreras A; Lopez-Medina C; Collantes-Estevez E; Jimenez-Gomez Y
    Hum Mol Genet; 2018 Mar; 27(5):875-890. PubMed ID: 29329380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris.
    Safari F; Damavandi E; Rostamian AR; Movassaghi S; Imani-Saber Z; Saffari M; Kabuli M; Ghadami M
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):326-337. PubMed ID: 34134454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of inflammation-related microRNA expression in patients with ankylosing spondylitis.
    Tan H; Ren R; Zhang J; Huang Z; Niu Q; Yang B
    Immunol Res; 2022 Feb; 70(1):23-32. PubMed ID: 34743291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.
    Ormseth MJ; Solus JF; Vickers KC; Oeser AM; Raggi P; Stein CM
    J Rheumatol; 2015 Oct; 42(10):1746-1751. PubMed ID: 26233505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.
    Tiedt S; Prestel M; Malik R; Schieferdecker N; Duering M; Kautzky V; Stoycheva I; Böck J; Northoff BH; Klein M; Dorn F; Krohn K; Teupser D; Liesz A; Plesnila N; Holdt LM; Dichgans M
    Circ Res; 2017 Sep; 121(8):970-980. PubMed ID: 28724745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposition of six well-characterized microRNAs to syndesmophytes among Chinese patients with ankylosing spondylitis.
    Yang W; Yan X; Xia Q; Tao Q; Gan X; Zhang Y; Chen Z; Kong W
    Mod Rheumatol; 2019 Jan; 29(1):173-180. PubMed ID: 29542383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction.
    Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F
    Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and identification of four serum miRNAs as novel potential biomarkers for cured pulmonary tuberculosis.
    Wang C; Yang S; Liu CM; Jiang TT; Chen ZL; Tu HH; Mao LG; Li ZJ; Li JC
    Tuberculosis (Edinb); 2018 Jan; 108():26-34. PubMed ID: 29523324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
    Yamano T; Kubo S; Sonoda E; Kominato T; Kimura K; Yasuhara M; Kataoka K; Son J; Babaya A; Takenaka Y; Matsubara T; Beppu N; Ikeda M
    PLoS One; 2021; 16(5):e0250072. PubMed ID: 33945535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
    Li J; Zhang M; Wang C
    J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
    Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
    J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
    Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
    Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.